{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:33:32Z","timestamp":1782257612079,"version":"3.54.5"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,2,20]]},"DOI":"10.18632\/oncotarget.23571","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T21:57:39Z","timestamp":1513893459000},"page":"11441-11450","source":"Crossref","is-referenced-by-count":30,"title":["CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases"],"prefix":"10.18632","volume":"9","author":[{"given":"Jie","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Saksena","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Hematology, Tianjin First Center Hospital, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Pathology, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Edition","author":"Thiele","year":"2017"},{"key":"2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Fend","year":"2009","journal-title":"Haematologica"},{"key":"3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Sargent","year":"2010","journal-title":"Cancer Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","article-title":"Aberrant Bcl6 protein expression in mantle cell lymphoma","volume":"28","author":"Piris","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1309\/UD2C6JVPWHXQQ217","article-title":"An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10","volume":"122","author":"Hanson","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1309\/U98ADVKUC26R2RJA","article-title":"B-cell lymphomas with coexpression of CD5 and CD10","volume":"119","author":"Weisberger","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1309\/T88X-71U4-WC0R-2531","article-title":"Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study","volume":"117","author":"Kroft","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2008.03060.x","article-title":"Mantle cell lymphoma with aberrant expression of CD10","volume":"53","author":"Bacon","year":"2008","journal-title":"Histopathology"},{"key":"9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1309\/AJCPV8LN5ENMZOVY","article-title":"Immunophenotypic variations in mantle cell lymphoma","volume":"132","author":"Chen","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jclinpath-2015-202955","article-title":"CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series","volume":"68","author":"Mansoor","year":"2015","journal-title":"J Clin Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"W\u00f6rmann","year":"2008","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAI.0b013e3181bb9edf","article-title":"BCL6, MUM1, and CD10 expression in mantle cell lymphoma","volume":"18","author":"Bacchi","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/his.13286","article-title":"Aberrant expression of CD10 and BCL6 in mantle cell lymphoma","volume":"71","author":"Sabattini","year":"2017","journal-title":"Histopathology"},{"key":"14","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Stilgenbauer","year":"2003","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Oscier","year":"2003","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma","volume":"68","author":"Rosenquist","year":"2002","journal-title":"Eur J Haematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/10428190801947559","article-title":"Molecular genetic characterization reveals new subsets of mantle cell lymphoma","volume":"49","author":"Rosenquist","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"18","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Campo","year":"2012","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Forstpointner","year":"2016","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/10428194.2013.815349","article-title":"Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database","volume":"55","author":"Michal","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"21","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2005-10-4079","article-title":"The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma","volume":"107","author":"Ott","year":"2006","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0609.2002.01677.x","article-title":"Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma","volume":"69","author":"Elonen","year":"2002","journal-title":"Eur J Haematol"},{"key":"23","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Borrebaeck","year":"2008","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","article-title":"The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival","volume":"143","author":"Sander","year":"2008","journal-title":"Br J Haematol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Dave","year":"2009","journal-title":"Haematologica"},{"key":"27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/modpathol.2015.99","article-title":"Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype","volume":"28","author":"Campo","year":"2015","journal-title":"Mod Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Palomero","year":"2012","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma","volume":"119","author":"Sander","year":"2012","journal-title":"Blood"},{"key":"30","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3109\/10428194.2011.600488","article-title":"Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network","volume":"52","author":"Hess","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3324\/haematol.2017.165795","article-title":"Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera","volume":"102","author":"Bueso-Ramos","year":"2017","journal-title":"Haematologica"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:56:13Z","timestamp":1589025373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,2,20]]}},"alternative-id":["23571","29545910"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23571","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}